ArticleCanadian oncology nursing journal = Revue canadienne de nursing oncologique2025
Cervical cancer treatment and nursing considerations: Best practices for effective care.
Article in Canadian oncology nursing journal = Revue canadienne de nursing oncologique, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past several decades, there has been excellent progress in cervical cancer prevention and early detection. However, there are still many Canadian woman who will be diagnosed with cervical cancer and will require active treatment. Advancements in personalizing treatment options based on specific staging and fertility-sparing preferences have helped decrease morbidities for some while ensuring well-needed aggressive treatment for others. Surgical procedures, for example, offer a variety of options with curative intent, particularly for those with earlier stage disease. Once the cancer has spread beyond the cervix to locally advanced stages 2 and 3, the combination of chemotherapy and radiation tends to be the mainstay treatment option. Finally, as cancer becomes more advanced into later stages 3 and 4 disease, utilizing traditional chemotherapy with the addition of novel drugs, such as monoclonal antibodies and immune check point inhibitors, offers hope where it was once lacking. This article focuses on these varying treatment options and identifies how nurses are in the prime position to help patients improve overall understanding, tolerance, and continuity of their treatment plan.
Identifiers
40874103PMC12379881What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.